Grant & Award Opportunities - Stand Up To Cancer

Grant & Award Opportunities

Stand Up To Cancer (SU2C) grants and awards fund cancer research projects that address critical problems in patient care and deliver near-term patient benefit through both individual and collaborative teams of expert investigators.

We are also committed to actively changing the health disparities landscape by supporting research and clinical trials that will develop successful strategies, measurable outcomes, and robust outreach to historically underrepresented racial and ethnic minority populations.

Core Principles

Patients can’t wait for new breakthroughs so SU2C does not operate on traditional grant cycles; rather we open Request For Applications (RFAs) as soon as funds are available. The core principles that guide our application selection process include:

  • Maximizing innovation while minimizing bureaucracy
  • Collaboration over competition
  • Advancing Health Equity in project goals and in grantee team makeup
  • Team environment to facilitate information sharing
  • Goal-oriented projects with defined milestones and deliverables
  • Regular progress reviews

Stand Up To Cancer is committed to eliminating barriers of access to new treatments for all cancer patients by harnessing the promise of precision medicine inclusive of diverse patient populations. We support clinical trials and research studies that have developed successful strategies, measurable outcomes, and robust outreach plans to include historically underrepresented racial and ethnic minority populations. We have developed a toolkit to assist in project planning.

Open Applications

Stand Up To Cancer strongly encourages novel, collaborative, and high-impact proposals. Proposals submitted in response to Requests for Applications (RFAs) are rigorously reviewed, and the most promising, exciting projects are selected by blue ribbon committees.

SU2C Lung Cancer Health Equity Research Team Grant Program

The SU2C Lung Cancer Health Equity Research Team Grant Program endeavors to quickly test new and emerging ideas in treatment of lung cancer in diverse populations and to prioritize new and innovative diagnostic and treatment methods for lung cancer.

Upcoming Areas of Interest

SU2C is interested in funding innovative research that has the potential to deliver life-saving results to all patients near-term, and supporting collaborations that focus on research in specific diseases or therapeutic approaches.

Areas of interest are best identified by our scientific leadership, strategic imperatives, and existing and emerging collaborations are ripe for breakthroughs that provide the most benefit to patients in the near term. Upcoming areas of interest include:

  • Artificial Intelligence/Machine Learning (AI/ML) Applications
  • Head & Neck Cancers and Lung Cancers
  • Cancer Interception
  • Pediatric Clinical Trials



When new areas of research are identified that could have significant patient impact and potential for breakthrough, SU2C acts quickly to push proposals in these areas from concept to reality. SU2C’s research teams study many cancer types, with a focus on today’s most innovative areas of cancer detection and therapy.


Pancreatic Cancer (19.5%)Leukemia/Leukaemia (7%)Lung Cancer (14.5%)Melanoma (5%)Breast Cancer (13%)Brain Tumor (3%)Not-Site Specific Cancer (10%)Ovarian Cancer (3%)Colon and Rectal Cancer (7%)Endometrial (2%)Prostate Cancer (8%)*Other Cancers (6%)

*Other Cancers (6%)

NeuroblastomaGenital System, MaleKidneyMyelomaNon-Hodgkin’s LymphomaGenital System, FemaleUrinary TractAnal CancerLiverSarcoma (soft-tissue)Cervical CancerLaryngealBone CancerGastrointestinalPharyngeal

Progress against one cancer is progress against all cancers.
See what SU2C scientists are working on now.



If you are interested in research funding opportunities, and being a part of SU2C’s scientific community, sign up for updates and follow @SU2CScience on Twitter.

   Please leave this field empty
Please validate the captcha

For more information on our grants, or your application, please email

Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.